Gliclazide + Metformin + Voglibose is a prescription tablet for adults with type 2 diabetes. It contains three medicines. Gliclazide is a sulfonylurea. Metformin, also called metformin hydrochloride, is a biguanide. Voglibose is an alpha-glucosidase inhibitor. Each one lowers blood sugar in a different way. Gliclazide helps the pancreas release more insulin. Metformin cuts down the sugar your liver makes. Voglibose slows how fast carbohydrates from food are turned into sugar in the gut. Doctors usually prescribe Gliclazide + Metformin + Voglibose when diet, exercise and one or two diabetes medicines no longer keep blood sugar in the target range.
Type 2 diabetes usually involves two problems. The body does not make enough insulin, and the insulin it does make does not work well. Gliclazide + Metformin + Voglibose acts on several parts of this problem at the same time.
Gliclazide works on the beta cells of the pancreas, which are the cells that make insulin. It prompts them to release more insulin. Gliclazide does this even when your blood sugar is already normal or low, which is why it can cause low blood sugar if you skip meals. Metformin works mostly in the liver. It reduces the amount of glucose (sugar) the liver releases into the blood, and it helps muscles respond better to insulin. Metformin does not raise insulin levels by itself. Voglibose works inside the small intestine. It slows the enzymes that break starch and table sugar down into glucose. This means sugar enters the blood more slowly after a meal, so the sharp rise in blood sugar after eating (called postprandial sugar) is smaller.
Gliclazide + Metformin + Voglibose is used in adults with type 2 diabetes whose blood sugar is not well controlled by diet, exercise and one or two diabetes medicines. It may also be used for people who are already stable on gliclazide, metformin and voglibose taken as separate tablets at the same strengths, so they have fewer pills to take. It is not used for type 1 diabetes or diabetic ketoacidosis (a dangerous build-up of acids in the blood caused by a severe lack of insulin).
This combination needs regular medical supervision. Gliclazide can cause low blood sugar (hypoglycaemia), especially if you skip meals, exercise more than usual or drink alcohol. Metformin carries a boxed warning for lactic acidosis. This is a rare but serious build-up of acid in the blood. It is more likely with kidney problems, liver disease, heavy drinking, dehydration or some X-ray dyes. Voglibose often causes gas and bloating, especially in the first few weeks.
Your doctor will check your blood sugar and HbA1c (your average sugar over about three months). Your kidney function will be tested before and during treatment. Vitamin B12 levels may also be checked during long-term use. Gliclazide + Metformin + Voglibose works best alongside a healthy diet, regular activity and weight control.
Common Side Effects (Usually Mild)
These often lessen as your body gets used to the medicine.
Serious Side Effects (Seek Urgent Medical Attention)
Gliclazide (sulfonylurea): Insulin-making beta cells in the pancreas have small "gates" on their surface called ATP-sensitive potassium channels. Gliclazide attaches to a part of these gates called the sulfonylurea receptor and closes them. When the gates close, the cell's electrical charge changes, calcium flows in, and the cell releases its stored insulin. This happens whatever your blood sugar level is, which is why gliclazide can cause low sugar. More insulin helps move sugar out of the blood and into body cells. Because gliclazide depends on working beta cells, it helps people whose pancreas still makes some insulin.
Metformin (biguanide): Metformin's main action is to slow down gluconeogenesis, which is the liver's process of making new glucose. This lowers the amount of sugar the liver releases, especially overnight and between meals. Metformin also helps muscle cells take in and use glucose and may slightly reduce sugar absorption from the gut. Part of this effect is thought to come through AMPK, an enzyme that senses energy levels inside cells. Metformin does not push the pancreas to release insulin, so on its own it rarely causes low sugar.
Voglibose (alpha-glucosidase inhibitor): The lining of the small intestine has enzymes called alpha-glucosidases. They break starch and sugars such as sucrose (table sugar) into glucose so it can be absorbed. Voglibose blocks these enzymes for a while. Carbohydrates are then broken down more slowly, and glucose enters the blood gradually instead of all at once. Some of the undigested carbohydrate reaches the large intestine, where gut bacteria ferment it. This explains the gas and bloating.
Working together: Gliclazide adds insulin, metformin lowers the sugar the liver releases and helps insulin work better, and voglibose evens out the after-meal sugar rise. Because they act at different sites, together they can lower blood sugar more than any one of them alone. Most of the low blood sugar risk comes from gliclazide. Metformin and voglibose rarely cause low sugar when used alone.
Gliclazide + Metformin + Voglibose is usually not recommended during pregnancy. Doctors generally switch to insulin to control blood sugar while pregnant. Sulfonylureas such as gliclazide can cause low blood sugar in the newborn if taken close to delivery. If you are planning a pregnancy, speak to your doctor early, as your treatment will usually be changed to insulin before you conceive.
Gliclazide + Metformin + Voglibose is not recommended while breastfeeding. Gliclazide may pass into breast milk and can cause low blood sugar in the baby, and there is not enough safety information for voglibose. Your doctor will usually switch you to a treatment that is safer while breastfeeding, such as insulin.
Avoid alcohol or keep it very limited. Alcohol raises the risk of lactic acidosis with metformin and can cause sudden or delayed low blood sugar with gliclazide.
Low blood sugar can cause dizziness, blurred vision or poor concentration. Check your sugar before driving if advised, keep a fast-acting glucose source in the vehicle, and do not drive if you feel any warning signs.
Metformin is removed from the body by the kidneys. Your doctor will check your kidney function with a blood test called eGFR (an estimate of how well your kidneys filter blood) before and during treatment. Gliclazide + Metformin + Voglibose must not be used if eGFR is below 30. It is usually not started if eGFR is between 30 and 45, and your doctor will review treatment if your eGFR falls below 45. Gliclazide is also avoided in severe kidney disease because it can cause long-lasting low blood sugar.
Liver disease raises the risk of both lactic acidosis and low blood sugar. Gliclazide + Metformin + Voglibose is generally avoided in significant liver disease.
Gliclazide + Metformin + Voglibose is not meant for children and teenagers under 18.
Older adults are more likely to get low blood sugar and to have reduced kidney function. Doctors often start with a lower strength and check kidney function more often.
Always tell your doctor and pharmacist about every medicine, supplement and herbal product you take.
Taking too much Gliclazide + Metformin + Voglibose can be dangerous. Possible effects include:
What to do: Get emergency medical help right away, even if the person seems well at first. If they are awake and able to swallow, give glucose tablets or glucose powder dissolved in water. Do not give food or drink to someone who is drowsy or unconscious. Take the medicine pack with you to the hospital. In hospital, glucose may be given into a vein, and the person may be watched for a long time.
Get urgent medical help if you notice:
Therapeutic Class
Antidiabetic (oral blood sugar-lowering combination)
Action Class
Sulfonylurea (insulin secretagogue) + Biguanide (insulin sensitiser) + Alpha-glucosidase inhibitor
Chemical Class
Sulfonylurea + Biguanide + Valiolamine derivative
Habit Forming
No
Checkout Editorial Policy
Top Selling Medicines
Top Health Products
Top Selling Devices
Gliclazide 80mg + Metformin 500mg + Voglibose 0.2mg

₹125

₹70.3
MRP ₹140.5
Gliclazide 80mg + Metformin 500mg + Voglibose 0.2mg

₹120

₹70.3
MRP ₹140.5
Gliclazide 80mg + Metformin 500mg + Voglibose 0.2mg

₹148.1

₹70.3
MRP ₹140.5
Gliclazide 40mg + Metformin 500mg + Voglibose 0.2mg

₹134.1

₹200.6
MRP ₹244.7
Gliclazide 80mg + Metformin 500mg + Voglibose 0.2mg

₹70.3
MRP ₹140.5
Gliclazide 80mg + Metformin 500mg + Voglibose 0.2mg

₹128

₹70.3
MRP ₹140.5
Gliclazide 80mg + Metformin 500mg + Voglibose 0.2mg

₹273.5

₹70.3
MRP ₹140.5
Gliclazide 80mg + Metformin 500mg + Voglibose 0.2mg

₹178.1

₹70.3
MRP ₹140.5
Gliclazide 40mg + Metformin 500mg + Voglibose 0.2mg

₹98.4

₹200.6
MRP ₹244.7
Gliclazide 40mg + Metformin 500mg + Voglibose 0.2mg

₹139.7

₹200.6
MRP ₹244.7
Gliclazide 80mg + Metformin 500mg + Voglibose 0.2mg

₹129.4

₹70.3
MRP ₹140.5
Gliclazide 40mg + Metformin 500mg + Voglibose 0.2mg

₹225.4

₹200.6
MRP ₹244.7
Gliclazide 80mg + Metformin 500mg + Voglibose 0.2mg

₹166.9

₹70.3
MRP ₹140.5
Gliclazide 40mg + Metformin 500mg + Voglibose 0.3mg

₹210.9

₹96.1
MRP ₹192.2
Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg

MRP ₹275.7
Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg

MRP ₹173.4
Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg

MRP ₹173.4
Gliclazide 1mg + Metformin 500mg + Voglibose 0.2mg

₹96

Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg

MRP ₹174.9
Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg

MRP ₹157
Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg

MRP ₹199
Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg

MRP ₹200
Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg

MRP ₹235.6
Gliclazide 60mg + Metformin 500mg + Voglibose 0.2mg

MRP ₹112.5
Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg

MRP ₹390